Publications

Export 94 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Aged  [Clear All Filters]
2015
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SKate, Vogel JW, Marks SM et al..  2015.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.. Brain. 138(Pt 7):2020-33.
Lipscombe C, Burns RJ, Schmitz N.  2015.  Exploring trajectories of diabetes distress in adults with type 2 diabetes; a latent class growth modeling approach.. J Affect Disord. 188:160-6.
Nazeri A, M Chakravarty M, Rotenberg DJ, Rajji TK, Rathi Y, Michailovich OV, Voineskos AN.  2015.  Functional consequences of neurite orientation dispersion and density in humans across the adult lifespan.. J Neurosci. 35(4):1753-62.
Blicher JUdby, Near J, Næss-Schmidt E, Stagg CJ, Johansen-Berg H, Nielsen JFeldbæk, Østergaard L, Ho Y-CLynn.  2015.  GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement.. Neurorehabil Neural Repair. 29(3):278-86.
Nazeri A, Roostaei T, Sadaghiani S, M Chakravarty M, Eberly S, Lang AE, Voineskos AN.  2015.  Genome-wide variant by serum urate interaction in Parkinson's disease.. Ann Neurol. 78(5):731-41.
Voineskos AN, Winterburn JL, Felsky D, Pipitone J, Rajji TK, Mulsant BH, M Chakravarty M.  2015.  Hippocampal (subfield) volume and shape in relation to cognitive performance across the adult lifespan.. Hum Brain Mapp. 36(8):3020-37.
Gerretsen P, Menon M, M Chakravarty M, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Vilaplana M, Richard-Devantoy S, Turecki G, Jaafari N, Jollant F.  2015.  Insight into mental disorders and suicidal behavior: a qualitative and quantitative multimodal investigation.. J Clin Psychiatry. 76(3):303-18.
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
Blair A, Gariépy G, Schmitz N.  2015.  The longitudinal effects of neighbourhood social and material deprivation change on psychological distress in urban, community-dwelling Canadian adults.. Public Health. 129(7):932-40.
Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage E, Ouellet M-C, Viscogliosi C, Belleville S.  2015.  Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study.. Int Psychogeriatr. 27(3):511-25.
Gariépy G, Thombs BD, Kestens Y, Kaufman JS, Blair A, Schmitz N.  2015.  The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis.. PLoS One. 10(7):e0133603.
Cloutier S, Chertkow H, Kergoat M-J, Gauthier S, Belleville S.  2015.  Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.. J Alzheimers Dis. 47(4):901-13.
Penner-Goeke K, Henriksen CA, Chateau D, Latimer E, Sareen J, Katz LY.  2015.  Reductions in quality of life associated with common mental disorders: results from a nationally representative sample.. J Clin Psychiatry. 76(11):1506-12.
Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, D Collins L.  2015.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.. Neurobiol Aging. 36 Suppl 1:S23-31.
Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JCS, Bellec P.  2015.  Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease.. Sci Data. 2:150043.
2016
Burns RJ, Deschênes SS, Schmitz N.  2016.  Associations between coping strategies and mental health in individuals with type 2 diabetes: Prospective analyses.. Health Psychol. 35(1):78-86.
Richard-Devantoy S, Ding Y, Turecki G, Jollant F.  2016.  Attentional bias toward suicide-relevant information in suicide attempters: A cross-sectional study and a meta-analysis.. J Affect Disord. 196:101-8.
DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, Massarweh G, Soucy J-P, Rosa-Neto P, Kobayashi E.  2016.  Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.. Eur J Nucl Med Mol Imaging. 43(1):152-62.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Gordon MForrest, Lenderking WR, Duhig A, Chandler J, J Lundy J, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S et al..  2016.  Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.. Alzheimers Dement. 12(1):75-84.
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.

Pages